Return to Web Version
Sigma-Aldrich
Life Science > Functional Genomics & RNAi > siRNA > MISSION® Positive Control siRNA
siRNA

MISSION® Positive Control siRNA


MISSION® Positive Control siRNA, designed using the Rosetta siRNA Design Algorithm, serve as an ideal complement to any siRNA silencing experiment. All MISSION® Positive Control siRNA have been validated to work*, so you can spend more time silencing your gene of interest and less time on optimizing internal controls.

Benefits of MISSION® Positive Control siRNA:

  • Simplified optimization of siRNA transfection efficiency
  • Increased target specificity, due to siRNA seed region optimization rules
  • Validated gene silencing
  • High quality siRNA produced at ISO 9000:2001 certified sites
  • Freedom to operate for research use

Available MISSION® Positive Control siRNA
Human
Product Gene
GAPDH glyceraldehyde-3-phosphate dehydrogenase
MAPK1 mitogen-activated protein kinase 1
KIF11 kinesin family member 11
Lamin A/C lamin A/C
Cyclophilin B (PPIB) peptidylprolyl isomerase B (cyclophilin B)
TP53 tumor protein p53 (Li-Fraumeni syndrome)

Rat
Product Gene
GAPDH glyceraldehyde-3-phosphate dehydrogenase
MAPK1 mitogen-activated protein kinase 1
Lamin A/C lamin A/C
Cyclophilin B (PPIB) peptidylprolyl isomerase B
TP53 tumor protein p53


*Mission Positive Control siRNA reduce the level of gene target by >75%, 24 hours after transfection with 30nM siRNA (HeLa or 9L/lacZ cells).

Back to siRNA
Back to Top

your favorite gene search

powered by ingenuity

Service & Support
Ordering
Corporate

©2011 Sigma-Aldrich Co. LLC. All rights reserved. SIGMA, SAFC, SIGMA-ALDRICH, ALDRICH, and SUPELCO are trademarks of Sigma-Aldrich Co. LLC, registered in the US and other countries. FLUKA is a trademark of Sigma-Aldrich GmbH, registered in the US and other countries. Sigma brand products are sold through Sigma-Aldrich, Inc. Purchaser must determine the suitability of the product(s) for their particular use. Additional terms and conditions may apply. Site Use Terms | Privacy

  • YouTube
  • Twitter
  • LinkedIN
  • Facebook